Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...101102103104105106107108109110...
CompanyDrug NameStatusIndication Group
Genvec No drug name in Phase IIAnti-infectives for systemic use
Advanced Biotherapy No drug name in Phase IAnti-infectives for systemic use
Bayer No drug name in Phase IIAnti-infectives for systemic use
Pfizer No drug name discontinuedAnti-infectives for systemic use
Schering-Plough No drug name in Phase IIAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IIAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IIAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IAnti-infectives for systemic use
Pfizer No drug name in Phase IIIAnti-infectives for systemic use
Tanox No drug name accomplished Phase IIAnti-infectives for systemic use
AlphaVax No drug name accomplished Phase IAnti-infectives for systemic use
NeurogesX No drug name accomplished Phase IIINervous system
Seattle Genetics No drug name accomplished Phase IAntineoplastic & immunomodulating agents
Astellas Pharma No drug name in Phase IIAntineoplastic & immunomodulating agents
Spectrum No drug name Submitted for approval in EUAntineoplastic & immunomodulating agents
Abbott Laboratories No drug name in Phase IISystemic hormonal preparations
Schering-Plough No drug name in Phase IIGenito urinary system & sex hormones
AstraZeneca No drug name in Phase IIIAntineoplastic & immunomodulating agents
...101102103104105106107108109110...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.